Mettez-vous hors ligne avec l'application Player FM !
Human Genome Sciences Benlysta Drug Approval for Lupus Patients
Série archivée ("Flux inactif" status)
When? This feed was archived on October 21, 2023 05:48 (). Last successful fetch was on September 28, 2019 01:48 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 151514514 series 1029942
BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
5 episodes
Série archivée ("Flux inactif" status)
When? This feed was archived on October 21, 2023 05:48 (). Last successful fetch was on September 28, 2019 01:48 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 151514514 series 1029942
BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
5 episodes
همه قسمت ها
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.